Integrated One-stop Drug Discovery Platform Accelerating Project with High Efficiency
Inflammatory and autoimmune diseases are a large group of disorders that encompasses a vast variety of human diseases, such as psoriasis, rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, multiple sclerosis and inflammatory bowel disease etc. Hunting medicines to address these unmet medical needs are one of the most popular therapeutic areas for drug discovery. HitGen dedicates to provide solution to drug discovery of inflammatory and autoimmune diseases area.
Services for inflammatory and autoimmune diseases drug discovery and development
Target validation
Recombinant target protein production
Biochemical assays development
DEL screening
Hit identification and generation
Hit-to-lead
Lead optimization
Fragment-based drug discovery and structure-based drug discovery
Co-crystal structure generation and resolution
In vitro efficacy and ADME evaluation
In vivo pharmacology (IMQ, EAE Modeling)
Drug metabolism and pharmacokinetics (DMPK)
Safety study
IND submission
HitGen Inc.
Building C2, NO.8, Huigu 1st East Road
Tianfu International Bio-Town,
Shuangliu District, Chengdu City,
Sichuan Province,P.R. China
Tel : +86-28-8519-7385
HitGen Pharmaceuticals Inc.(US Subsidiary)
Tel : +1-(508)-840-9646
Vernalis (R&D) Limited (UK Subsidiary)
Granta Park,Great Abington
Cambridge,CB21 6GB
United Kingdom
Tel : +44(0)1223-895555
We use cookies to provide a better web experience.
By using our site, you acknowledge our use of cookies and please read our Cookie Notice for
More information